We are live on ! Find out more
OPRX icon

OptimizeRx

86 hedge funds and large institutions have $310M invested in OptimizeRx in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 5

251% more call options, than puts

Call options by funds: $8.51M | Put options by funds: $2.42M

58% more capital invested

Capital invested by funds: $197M → $310M (+$114M)

33% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 24

26% more funds holding

Funds holding: 6886 (+18)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

2.4% more ownership

Funds ownership: 63.6%66% (+2.4%)

Holders
86
Holders Change
+18
Holders Change %
+26.47%
% of All Funds
1.52%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.11%
New
23
Increased
32
Reduced
24
Closed
5
Calls
$8.51M
Puts
$2.42M
Net Calls
+$6.08M
Net Calls Change
+$3.87M

OPRX Hedge Fund Activity: Q4 2020 in Review

86 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2020, worth a combined $310M — up 58% from $197M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new OPRX positions and 5 closed out — a net gain of 18 holders — while 32 added to existing stakes and 24 trimmed.

The largest buyer was Next Century Growth Investors, opening a new position worth an estimated $5.49M. The largest seller was G2 Investment Partners Management, cutting an estimated $5.62M.

  • 86 institutional investors held OptimizeRx (OPRX) as of Q4 2020, up from 68 in Q3 2020.
  • Funds reported $310M of OptimizeRx stock for Q4 2020, up 58% quarter-over-quarter.
  • 23 funds opened new OptimizeRx positions in Q4 2020 and 5 closed out, a net change of +18 holders.
  • The largest OptimizeRx buyer in Q4 2020 was Next Century Growth Investors, an estimated $5.49M added.
  • The largest OptimizeRx seller in Q4 2020 was G2 Investment Partners Management, an estimated $5.62M sold.

Based on aggregated 13F filings for Q4 2020.